Brief: Acasti Announces Dosing Of First Patient In Gtx-104 Strive-On Trial

Grace Therapeutics

23/10/2023 13:16

Oct 23 (Reuters) - Acasti Pharma Inc  ACST.O :
    * ACASTI ANNOUNCES DOSING OF FIRST PATIENT IN GTX-104
STRIVE-ON
TRIAL
    * ACASTI PHARMA INC - PIVOTAL STRIVE-ON SAFETY TRIAL ON
TRACK FOR
POTENTIAL NDA SUBMISSION ANTICIPATED TO OCCUR IN FIRST HALF OF
CALENDAR 2025

Source text for Eikon:  ID:nGNX1bKnwS 
Further company coverage:  ACST.O 

 ((Reuters.Briefs@thomsonreuters.com;))